Applied DNA Sciences Inc (APDN): 'apdn1mill' - I thought it was a Lawyer...

titi · 2015-10-30T16:44:04.0300000Z

'apdn1mill' - I thought it was a Lawyer but I called them back today and found out it was an Investment Relations Firm. Their phone number is 212 838-3777.

Play Episode

7min

Proactive - Interviews for investors

Graphene Manufacturing Group advances aluminium-ion battery development with key U.S. partnership

Graphene Manufacturing Group CEO Craig Nicol joined Steve Darling from Proactive to share an update as the company continues to make strides in the development of its Graphene Aluminium-Ion Battery technology, a cutting-edge innovation being pursued in collaboration with the University of Queensland and Rio Tinto under a Joint Development Agreement. Nicol told Proactive, to accelerate battery development, GMG has signed a service contract with the Battery Innovation Center (BIC) in Indiana, USA. This partnership will support the next phase of research and optimization, leveraging BIC’s state-of-the-art 40,000-square-foot facility in Newberry, Indiana. As a globally recognized innovation hub, BIC specializes in advancing battery technologies, offering end-to-end support from research and development to prototype manufacturing and low-volume production—a critical advantage for GMG as it scales up its graphene-based energy storage solutions. Nicol emphasized that collaborating with BIC allows GMG to access advanced battery manufacturing infrastructure without incurring the high capital costs of building its own pilot production facility—an investment that could exceed AU$10 million. Through this agreement, GMG will retain full intellectual property (IP) rights over the battery development work, ensuring control over its proprietary technology while optimizing BIC’s cell design expertise and battery manufacturing capabilities. By integrating BIC’s expertise into its scale-up strategy, GMG can streamline the production of sample battery cells before committing to mass production, reducing risks and deferring large capital expenditures until the technology reaches a higher level of readiness. Looking ahead, GMG aims to optimize battery performance, produce initial test cells this year, and engage customers for validation. Nicol noted strong interest from major companies eager to integrate this technology. #proactiveinvestors #graphenemanufacturinggroupltd #BatteryTech #

Proactive - Interviews for investors

Jindalee Lithium's McDermitt Project: Major US lithium asset - PDAC 2025

Jindalee Lithium Ltd (ASX:JLL, OTCQX:JNDAF) CEO Ian Rodger talked with Proactive about the company's McDermitt project, a large-scale lithium resource on the Oregon-Nevada border. The project is among the most advanced sedimentary lithium assets in the US. Rodger discussed the company’s recent pre-feasibility study, highlighting its potential as a multi-generational, low-cost source of battery-grade lithium. He also addressed the company’s recent asset sale, which generated approximately 3 million AUD. Rodger emphasized Jindalee's long-standing strategy of creating shareholder value through exploration success, joint ventures, and asset sales. With a strong financial position, the company aims to progress key catalysts in 2025, including a Department of Defense grant application and permitting milestones. Rodger also noted the company’s discussions with potential partners to fund the next development stage of the McDermitt project. He stated, "We’re positioning the company for success in 2026, with key funding and strategic milestones ahead." For more interviews and updates, visit Proactive’s YouTube channel. Don’t forget to like, subscribe, and turn on notifications! #JindaleeLithium #LithiumMining #BatteryMetals #EVRevolution #MiningStocks #LithiumSupply #EnergyTransition #CriticalMinerals #Investing #PDAC2025

Proactive - Interviews for investors

Millennial Potash advances Banio Project with resource potential and government support

Millennial Potash Corp (TSX-V:MLP, OTCQB:MLPNF) is advancing its Banio Potash Project in Gabon, leveraging extensive historical data and significant resource potential. Speaking at the PDAC conference in Toronto, Chairman Farhad Abasov shared key updates with Proactive’s Angela Harmantas, highlighting the project’s economic viability, strategic location, and government support. A recently completed economic assessment confirmed a 1.7 billion tonne indicated and inferred resource estimate, reinforcing the project’s scale and cost competitiveness. Abasov emphasized Banio’s proximity to major agricultural markets such as Brazil, India, China, and Africa, ensuring strong demand for its potash production. Gabon’s mining reforms have strengthened the project’s outlook, with the government actively supporting the Banio Project. Abasov noted a recent visit from the country’s president, signaling confidence in its economic and strategic value. Key milestones for 2024 include ongoing environmental studies, a second phase of drilling to expand the resource base, and the initiation of a feasibility study, which will run parallel to environmental assessments and is expected to conclude by early 2025. With strong backing, a large resource base, and a clear path to development, Millennial Potash is positioning itself as a major future supplier of potash, supporting global food security while contributing to Gabon’s economic growth. #tsxv #mlp #otcqb #mlpnf MillennialPotash #PotashMining #GabonMining #BanioProject #MiningInvestment #NaturalResources #MiningStocks #Commodities #SustainableMining #ProactiveInvestors

Proactive - Interviews for investors

Creo Medical CEO on 2024 milestones & 2025 growth plans

Creo Medical Group PLC CEO Craig Gulliford talked with Proactive's Stephen Gunnion about the company’s 2024 performance and its strategy for 2025. He highlighted strong growth in Creo’s core technology platform, particularly in the US market, as well as the successful launch of the Speedboat UltraSlim device. Gulliford also discussed the introduction of the SpydrBlade product, which is set for a full market release in 2025 alongside several other new product launches. He emphasised that Creo Medical is shifting from a development-stage company to a commercially profitable business, supported by both revenue growth and cost management. In addition, he spoke about the completion of a €30 million deal with Micro-Tech, where Creo sold a 51% stake in Creo Medical Consumables Europe. This transaction enhances the company’s supply chain security and strengthens its direct sales channel in Europe. He noted that the valuation of the business has more than doubled since its acquisition four and a half years ago. Gulliford confirmed that the company’s cash reserves have been bolstered by the deal, allowing further investment in expansion across Europe, the US, and emerging markets in South America and Asia. He also highlighted progress in Creo’s partnership with Intuitive on the Kamaptive platform, which has entered a commercialisation phase following the first robotically guided lung tumour ablation. Looking ahead, investors can expect key milestones in 2025, including new product launches, further site expansions for Kamaptive, and continued revenue growth. For more exclusive interviews, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for future updates. #CreoMedical #MedicalTechnology #HealthcareInnovation #Endoscopy #SurgicalDevices #Kamaptive #CraigGulliford #ProactiveInvestors #StockMarket #Investing

Followers	10
Posts	1976
Boards Moderated	0
Alias Born	05/31/2006

Volume:	10,067
Day Range:
Bid:	0.1314
Ask:	0.1368
Last Trade Time:	9:21:33 AM EDT
Total Trades:	49

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

APDN Detailed Quote

Recent APDN News

More APDN News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent APDN News

Go Ad-Free